DRUG · Unmapped registry intervention
CBP-1019
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
NCT05830097
Study summary
ClinicalTrials.govA Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Cancer, Breastcandidate · MONDO: breast cancer
Cancer, Lungcandidate · MONDO: lung cancer
Cancer of Esophagusverified · MONDO: esophageal cancer
Cancer Colorectalunresolved
Interventions
CBP-1019DRUG
Sponsors & collaborators
Coherent Biopharma (Hefei) Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05830097 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.